close
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Mar;5(2):120-7.
doi: 10.1097/COH.0b013e328335c2f6.

Th17 cytokines in mucosal immunity and inflammation

Lokesh Guglani  1 , Shabaana A Khader
Affiliations
Review

Th17 cytokines in mucosal immunity and inflammation

Lokesh Guglani et al. Curr Opin HIV AIDS. 2010 Mar.

Abstract

Purpose of review: Compelling evidence suggests that the Th17 lineage and other IL-17-producing cells play critical roles in host defense against pathogens at mucosal sites. However, IL-17 can also contribute to inflammatory responses at mucosal sites. In this review, we will discuss the recent progress in our understanding of the role of Th17 and other IL-17-producing cells in defining the fine balance between immunity and inflammation at different mucosal sites. RECENT FNDINGS: Recent findings have highlighted that Th17 cytokines are important for the induction of innate and adaptive host responses and contribute to host defense against pathogens at mucosal sites. More recent developments have probed how the Th17 responses are generated in vivo in response to infections and their requirement in maintaining barrier function at mucosal sites. Most importantly, it is becoming apparent that there is a fine balance between protective and pathological manifestation of Th17 responses at mucosal sites that defines immunity or inflammation.

Summary: In this review, we have summarized the recent advances in our understanding of Th17 cytokines and how they contribute to immunity versus inflammation at mucosal sites.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicting financial interests.

Figures

Figure 1
Figure 1. Role of Th17 cytokines in protection versus pathology at the mucosal surfaces
Infection-induced IL-17 and IL-22 can be produced by several immune cells found in mucosal sites. One of the targets of IL-17 and IL-22 are mucosal epithelial cells, where IL-17 augments G-CSF and CXC chemokine production resulting in recruitment of neutrophils, monocytes and other inflammatory cells that contribute to bacterial, fungal and viral clearance at mucosal sites. However, the resulting cellular infiltration can cause resulting inflammation and damage at mucosal surfaces. IL-17 can synergize with IL-22 and induce antimicrobial peptides and epithelial repair function important for control of extracellular pathogens. IL-17 can also act directly on APCs and induce cytokines such as IL-12 and drive Th1 differentiation required for intracellular pathogen clearance.
See this image and copyright information in PMC

References

    1. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005 Nov;6(11):1133–41. - PMC - PubMed
    1. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005 Nov;6(11):1123–32. - PubMed
    1. Dong C. IL-23/IL-17 biology and therapeutic considerations. J Immunotoxicol. 2008 Jan;5(1):43–6. - PubMed
    1. Diveu C, McGeachy MJ, Cua DJ. Cytokines that regulate autoimmunity. Curr Opin Immunol. 2008 Dec;20(6):663–8. - PubMed
    1. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005 Jan 17;201(2):233–40. - PMC - PubMed

Publication types